Literature DB >> 8659891

Production of antibody fragments in Escherichia coli.

J S Harrison1, E Keshavarz-Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8659891     DOI： 10.1111/j.1749-6632.1996.tb40556.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Construction, expression and in vitro biological behaviors of Ig scFv fragment in patients with chronic B cell leukemia.

Authors:  Lijuan Zhu; Wenjun Liao; Huifen Zhu; Ping Lei; Zhihua Wang; Jingfang Shao; Yue Zhang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 2.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

Review 3.  With or without sugar? (A)glycosylation of therapeutic antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

4.  The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi.

Authors:  Vivi Joosten; Christien Lokman; Cees AMJJ Van Den Hondel; Peter J Punt
Journal:  Microb Cell Fact       Date:  2003-01-30       Impact factor: 5.328
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.